RES before ischemia exerts a potent neuroprotective effect with an efficacious time window of at least 4 h via the national marine distributors association (NMDA) receptor-mediated ERK1/2-cAMP-response element binding protein (CREB) pathway. Here, MAPK3 is linked to ischemia.